Can a regimen including tenapanor (tenapanor), linaclotide (linaclotide), and various supplements such as lipo NMN (nicotinamide mononucleotide), TMG (trimethylglycine), resveratrol, and others cause skin itchiness, strange sensations, and mild excoriations in a patient with pre-diabetes and Irritable Bowel Syndrome with Constipation (IBS-C)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Polypharmacy-Related Pruritus and Sensory Symptoms: Immediate Medication Review Required

This patient's skin itchiness, strange sensations in arms and torso, and mild excoriations without visible rash are highly concerning for drug-induced pruritus and should prompt immediate systematic medication review, with particular attention to niacin-containing supplements (NMN), berberine, and rapamycin as the most likely culprits.

Primary Suspects for Drug-Induced Pruritus

High-Risk Supplements in This Regimen

  • Niacin/NMN (Nicotinamide Mononucleotide) is the most likely cause of pruritus and abnormal sensations, as niacin commonly causes flushing, pruritus, and paresthesias through prostaglandin-mediated mechanisms 1

  • Berberine can cause pruritus and skin reactions in susceptible individuals, particularly at higher doses used for glycemic control 1

  • Rapamycin (sirolimus) is associated with pruritus in 15% of patients and can cause skin toxicity including xerotic skin, which exacerbates itching 2, 1

  • Resveratrol has limited safety data in humans, with insufficient evidence to rule out adverse cutaneous effects 3

Immediate Management Algorithm

Step 1: Discontinue Most Likely Offenders (Week 1)

  • Stop NMN/niacin-containing supplements immediately - this is the single most likely cause of flushing-type pruritus with paresthesias 1

  • Discontinue rapamycin temporarily - given its known association with pruritus and xerotic skin 2, 1

  • Hold berberine - particularly if using doses >1000mg daily for pre-diabetes management 1

Step 2: Symptomatic Treatment During Washout Period

  • Apply moderate-to-high potency topical corticosteroid (e.g., triamcinolone 0.1% cream) to affected areas twice daily for pruritus control 4

  • Apply emollients at least once daily to the whole body to restore skin barrier function - use oil-in-water creams or ointments, avoiding alcohol-containing lotions 4, 5

  • Use topical menthol 0.5% or cooling antipruritic lotions for immediate symptomatic relief of itching 4

  • Consider diphenhydramine 25-50 mg or hydroxyzine 25-50 mg at bedtime only if nighttime pruritus is disrupting sleep 4

Step 3: Reassess After 2 Weeks

  • If symptoms resolve completely - the discontinued medications were causative; do not restart them 4, 1

  • If symptoms persist but improve - continue topical therapy and consider short-term oral systemic corticosteroids 4

  • If no improvement - consider dermatology referral and evaluate for other causes including drug-induced cholestasis from metformin or other hepatotoxic supplements 1

Additional Concerning Drug Interactions

Metformin (Glucophage) Interactions

  • Multiple supplements in this regimen may potentiate metformin's effects, increasing risk of lactic acidosis, particularly berberine which has additive glucose-lowering effects 3

  • Monitor for signs of lactic acidosis including muscle pain, unusual fatigue, or respiratory distress given the combination of metformin with multiple metabolically active supplements 3

Rapamycin-Specific Concerns

  • Weekly rapamycin use for "anti-aging" is off-label and carries significant immunosuppressive risks including increased infection susceptibility 1

  • Rapamycin commonly causes xerotic skin (dry skin) in >50% of patients on long-term therapy, which directly exacerbates pruritus 2

Critical Pitfalls to Avoid

  • Do not use topical calamine lotion or crotamiton cream - evidence shows they lack efficacy for drug-induced pruritus 4

  • Avoid topical neomycin-containing preparations - neomycin causes sensitization in 5-15% of patients with chronic dermatitis and could worsen symptoms 4

  • Do not assume antihistamines alone will resolve drug-induced pruritus - they are specifically effective for urticaria but have limited efficacy when histamine is not the primary mediator 4, 1

  • Avoid hot showers and excessive soap use - these cause skin dehydration and worsen pruritic symptoms 4

Monitoring for Serious Complications

  • Watch for secondary bacterial infection from excoriations, which requires topical or systemic antibiotics 4

  • Monitor closely given pre-diabetes status - patients with diabetes have increased risk of secondary bacterial infection from skin breakdown 4

  • Assess for sleep disturbance and quality of life impact - severe pruritus commonly affects these domains and may require more aggressive intervention 6

Long-Term Supplement Rationalization

This patient is taking 30+ supplements/medications simultaneously, creating substantial risk for:

  • Drug-drug interactions that are impossible to predict with this level of polypharmacy 1
  • Cumulative hepatotoxic effects from multiple supplements processed through similar pathways 1
  • Difficulty identifying causative agents when adverse events occur 1

Strongly recommend systematic reduction to evidence-based therapies only: metformin for pre-diabetes, linaclotide or tenapanor for IBS-C, and vitamin D if deficient 2, 3

References

Research

Drug-Induced Itch Management.

Current problems in dermatology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Resveratrol for adults with type 2 diabetes mellitus.

The Cochrane database of systematic reviews, 2020

Guideline

Assessment and Management of Diffuse Pruritus Following Debris Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical treatment of ichthyoses.

Dermatologic therapy, 2013

Research

Burden of skin pain in atopic dermatitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.